E Bergogne-Bérézin
- Molecular Medicine top 0.1%
- Endocrinology top 0.2%
- Epidemiology top 5%
- Molecular Biology top 10%
- Pharmacology top 1%
- Co-authors
- K. J. TownerMarie‐Laure Joly‐GuillouJ.F. VieuE ValléeG BerthelotDominique DecréClaudette Muller‐SerieysJ Pierre
- Topics
- Antibiotic Resistance in Bacteria (85 papers)Antibiotics Pharmacokinetics and Efficacy (62 papers)Pneumonia and Respiratory Infections (36 papers)
In The Last Decade
E Bergogne-Bérézin
152 papers receiving 3.2k citations
Hit Papers
Peers
Comparison fields: 5 of 130
- Molecular Medicine 2.2k
- Endocrinology 1.1k
- Epidemiology 931
- Molecular Biology 924
- Pharmacology 803
Countries citing papers authored by E Bergogne-Bérézin
This map shows the geographic impact of E Bergogne-Bérézin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Bergogne-Bérézin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Bergogne-Bérézin more than expected).
Fields of papers citing papers by E Bergogne-Bérézin
This network shows the impact of papers produced by E Bergogne-Bérézin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Bergogne-Bérézin. The network helps show where E Bergogne-Bérézin may publish in the future.
Co-authorship network of co-authors of E Bergogne-Bérézin
This figure shows the co-authorship network connecting the top 25 collaborators of E Bergogne-Bérézin. A scholar is included among the top collaborators of E Bergogne-Bérézin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Bergogne-Bérézin. E Bergogne-Bérézin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Les fluoroquinolones dans l'infection urinaire : pyélonéphrite aiguë et prostatite de l'adulte | 1 |
| 2 | 121 | |
| 3 | 11 | |
| 4 | [Ecologic impact of antibiotherapy. Role of substitution microorganisms in the control of antibiotic-related diarrhea and colitis]. | 14 |
| 5 | [Azithromycin: tissue pharmacology]. | 2 |
| 6 | 6 | |
| 7 | 24 | |
| 8 | 5 | |
| 9 | 13 | |
| 10 | 42 | |
| 11 | 10 | |
| 12 | 14 | |
| 13 | [Comparative activity in vitro of ceftizoxime, ceftazidime and imipenem against Acinetobacter calcoaceticus]. | 2 |
| 14 | 2 | |
| 15 | 7 | |
| 16 | [Medical economics and optimal antibiotic therapy]. | 1 |
| 17 | Epidémiologie d'Acinetobacter calcoaceticus. | 12 |
| 18 | [Pharmacokinetic study of antibiotics in human respiratory tract (author's transl)]. | 6 |
| 19 | [The influence of rifampicin upon the metabolism of isoniazid (author's transl)]. | 3 |
| 20 | Septicémie a Torulopsis glabrata | 0 |
About E Bergogne-Bérézin
E Bergogne-Bérézin is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Endocrinology, having authored 163 papers that have together received 3.4k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (85 papers), Antibiotics Pharmacokinetics and Efficacy (62 papers) and Pneumonia and Respiratory Infections (36 papers). The work is most often cited by research in Molecular Medicine (2.2k citations), Endocrinology (1.1k citations) and Applied Microbiology and Biotechnology (276 citations). E Bergogne-Bérézin has collaborated with scholars based in France, Italy and Serbia. Frequent co-authors include K. J. Towner, Marie‐Laure Joly‐Guillou, J.F. Vieu, E Vallée, G Berthelot, Dominique Decré, Claudette Muller‐Serieys, J Pierre, A. Philippon and P Even. Their work appears in journals such as Clinical Microbiology Reviews, Clinical Infectious Diseases and Journal of Clinical Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.